The price of Opzelura cream can vary significantly when using insurance. Factors influencing the out-of-pocket cost include the specific insurance plan, pharmacy, and whether the patient has met their deductible [1].
How much does Opzelura cream cost without insurance?
Without insurance, the list price for Opzelura cream can be substantial. For example, a 60-gram tube might cost upwards of $1,900 [1]. However, drug prices can fluctuate, and it's advisable to check current pricing.
What financial assistance programs are available for Opzelura?
For eligible patients with commercial prescription drug insurance who meet certain criteria, a savings card program may be available. This program can potentially reduce out-of-pocket costs, with maximum savings amounts specified by the manufacturer [1]. Details on eligibility and program terms are typically found on the manufacturer's website or through healthcare providers.
What is Opzelura used for?
Opzelura (ruxolitinib) is a topical medication approved for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older whose disease is not adequately controlled with topical therapies [2]. It is also indicated for the topical treatment of nonsegmental vitiligo in patients 12 years of age and older [2].
How does Opzelura work?
Opzelura contains ruxolitinib, a Janus kinase (JAK) inhibitor. By inhibiting JAK pathways, it helps reduce inflammation associated with atopic dermatitis and can also help with repigmentation in vitiligo [2].
When does Opzelura patent expire?
Information on specific patent expiry dates for Opzelura is complex and involves multiple patents covering composition of matter, methods of use, and formulation. DrugPatentWatch.com provides a database that tracks patent information for pharmaceuticals [3]. Pharmaceutical patents typically last for 20 years from the filing date, but extensions and other intellectual property strategies can affect market exclusivity [3].
What are the common side effects of Opzelura?
Common side effects of Opzelura cream include upper respiratory tract infections, itching, diarrhea, ear infections, increased eosinophil counts, headache, dizziness, abdominal pain, nausea, and increased white blood cell counts [2].
Who makes Opzelura?
Opzelura is manufactured by Incyte Corporation [1][2].
Sources:
1. https://www.opzelura.com/
2. https://www.opzelura.com/about-opzelura/how-it-works
3. https://drugpatentwatch.com/